Intravenous anti-influenza drug oseltamivir will not induce torsade de pointes: Evidences from proarrhythmia model and action-potential assay

J Pharmacol Sci. 2016 May;131(1):72-5. doi: 10.1016/j.jphs.2016.04.018. Epub 2016 Apr 22.

Abstract

We evaluated proarrhythmic risk of intravenous oseltamivir with chronic atrioventricular block canine model (n = 4) and action-potential assay on guinea-pig right ventricle (n = 5). Oseltamivir in doses of 3-30 mg/kg, i.v. did not induce torsade de pointes in the canine model, whereas that in concentrations of 30-300 μM decreased maximum rate of phase 0 depolarization, shortened action potential duration at 30%, 60% and 90% repolarization levels, but prolonged difference in action-potential duration between 30% and 90% repolarization levels in a concentration-related manner. These results indicate that oseltamivir will not induce torsade de pointes clinically, since it inhibits both inward and outward currents.

Keywords: Intravenous; Oseltamivir; Torsade de pointes.

MeSH terms

  • Action Potentials / drug effects*
  • Animals
  • Antiviral Agents / pharmacology*
  • Atrioventricular Block
  • Biological Assay
  • Dogs
  • Female
  • Guinea Pigs
  • Heart / drug effects
  • Heart / physiology
  • Humans
  • In Vitro Techniques
  • Influenza, Human / drug therapy
  • Male
  • Oseltamivir / pharmacology*
  • Torsades de Pointes

Substances

  • Antiviral Agents
  • Oseltamivir